Pharma News

Nearly three-quarters of parents begin deciding which vaccines they want to give to their child before pregnancy, US-based research has found.

Fans of the vampire "Twilight" film series have been warned that they could be putting their sight at risk by sharing cosmetic contact lenses bought online, the media reported on Saturday.

Alexion Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved Strensiq (asfotase alfa) for the treatment of patients with perinatal-, infantile- and juvenile-onset hypophosphatasia (HPP).

[adsense:336x280:8701650588]

A new study says that delivering the hormone leptin directly to the brain through gene therapy aids weight loss without much side effect of bone loss. The findings were published in the Journal of Endocrinology.

Allergan plc, a leading global pharmaceutical company, announced the launch of the over-the-counter artificial tear Refresh Optive gel drops, a new aqueous gel expertly designed for patients to relieve their dry eye symptoms. New Refresh Optive Gel Drops are formulated with Glycerin and a unique blend of the active ingredient CMC which binds to the eye surface to provide long-lasting relief from dry eye discomfort.

US Food and Drug Administration’s (FDA) Arthritis Advisory Committee (AAC) voted 10 to 4 to recommend the approval of lesinurad 200mg tablets for the treatment of hyperuricemia associated with gout, in combination with a xanthine oxidase inhibitor (XOI). All 10 who backed the drug, lesinurad, qualified their vote by urging the FDA to ask AstraZeneca for studies after the drug's launch to gauge its long-term effectiveness and safety.

A new study has suggested that the chemical produced by decaying tissue of dead bodies can produce a fight-or-flight response in humans. This is the first study to show that a scent emanating from a specific chemical compound called putrescine can be processed as a threat signal. The study was published in Frontiers in Psychology.

Aurobindo Pharma Limited has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market  Tramadol Hydrochloride Extended -release Tablets USP, 100 mg, 200 mg and 300 mg.

AstraZeneca and Eli Lilly deepening their collaboration in cancer immunotherapy by testing new drug combinations for treating solid tumours.

There is good news for people suffering from hair loss. In experiments with mouse and human hair follicles, researchers have found that certain existing drugs promote rapid and robust hair growth when directly applied to the skin.